Prevention of Bacteremia Induced by Debridement of Pressure Ulcer
NCT ID: NCT00269100
Last Updated: 2007-04-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
60 participants
OBSERVATIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
DEFINED_POPULATION
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* With contaminated pressure ulcers
* Going to have a debridement procedure
Exclusion Criteria
* Bacteremia that does not react to the antibiotic treatment
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Herzog Hospital
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Efraim Jaul
Role: STUDY_DIRECTOR
Herzog Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Herzog Hospital
Jerusalem, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Jaul1CTIL
Identifier Type: -
Identifier Source: org_study_id